Brief: Vivesto Announces Early Termination Of Patient Enrollment

Vivesto AB

04/08/2023 09:05

Aug 4 (Reuters) - Vivesto AB  VIVE.ST :
    * VIVESTO ANNOUNCES EARLY TERMINATION OF PATIENT ENROLLMENT
IN THE
INVESTIGATOR-INITIATED PHASE 1B DOCETAXEL MICELLAR STUDY
    * EARLY TERMINATION OF PATIENT ENROLLMENT IN DOCETAXEL
MICELLAR
ADVANCED PROSTATE CANCER PHASE 1B STUDY WITH SWISS GROUP FOR
CLINICAL CANCER RESEARCH (SAKK)
    * BELIEVES THAT DATA GENERATED WILL BE SUFFICIENT AHEAD OF
SWITCHING INTO DEVELOPMENT WITH A NEW FORMULATION BASED ON ITS
IMPROVED XR-18 MICELLE TECHNOLOGY PLATFORM

Source text for Eikon:  ID:nMFN1wHW0N 
Further company coverage:  VIVE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))